region:eastern myanmar

  • Unemployed, Myanmar’s Elephants Grow Antsy, and Heavier - The New York Times
    http://www.nytimes.com/2016/01/31/world/asia/myanmar-logging-elephants-unemployment.html

    Dragging giant tree trunks up and down the steep hillsides of sweltering jungles is a tough job. But there is something worse, say owners of Myanmar’s logging elephants: having no job at all.

    Shrinking forests and a law enacted three years ago that prohibits the export of raw timber have saddled Myanmar with an elephant unemployment crisis. Hundreds of elephants have been thrown out of work, and many are not handling it well.

    They become angry a lot more easily,” U Chit Sein, 64, whose eight logging elephants now work only a few days a month. “There is no work, so they are getting fat. And all the males want to do is have sex all the time.

    Elephants hold an almost mystical place in Myanmar, home to the world’s largest captive elephant population. For hundreds of years, they helped extract precious teak and hardwoods from jungles that even modern machinery still cannot penetrate.

    Now the future of the 5,500 or so wrinkled pachyderms in captivity is a major preoccupation for the government officials who oversee them.

    Unemployment is really hard to handle,” said U Saw Tha Pyae, whose six elephants have been jobless for the past two years. “There is no logging because there are no more trees.

    Myanmar’s leading elephant expert, Daw Khyne U Mar, estimates that there are now 2,500 jobless elephants, many of them here in the jungles of eastern Myanmar, about two and a half hours from the Thai border. That number would put the elephant unemployment rate at around 40 percent, compared with about 4 percent for Myanmar’s people.

  • #Resistance Taking Sting Out of Top #Malaria Drug - WSJ
    http://online.wsj.com/articles/resistance-taking-sting-out-of-top-malaria-drug-1406793789

    Resistance to the world’s most effective drug against malaria is becoming widespread in Southeast Asia, a recurrent pattern that threatens global efforts to control the mosquito-borne infectious disease, a new study shows.

    Resistance to the drug, #artemisinin, in the most deadly form of malaria-causing parasite, #Plasmodium falciparum, is established in northern and western Cambodia, Thailand, Vietnam and eastern Myanmar, according to the study published Thursday in the New England Journal of Medicine.

    The research, coordinated by the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, analyzed blood samples from 1,241 malaria patients in 10 Asian and African countries between 2011 and 2013.

    Fear is growing that resistance would spread from Asia to Africa—where progress has been made in reducing deaths from malaria—in a way that neutered previous treatments. So far, three African sites included in the study—in Kenya, Nigeria and Congo—showed no signs of resistance.

    This is the third time that the malaria parasite has developed resistance to drugs. Each time previously it emerged from the Cambodian-Thailand border and spread to other countries, including in Africa.

    Resistance to chloroquine spread from the late 1950s into the 1970s, resulting in a resurgence of malaria infections and millions of deaths. Then, sulphadoxine-pyrimethamine was introduced before a resistance emerged. It was replaced by artemisinin combination therapies.

    Resistance to artemisinin has been driven by the misuse of the drug eroding its efficacy. It takes six days of treatment to clear parasites in patients on the Thai-Cambodian border instead of the standard three, the study found.

    Researchers found that patients whose infections were slow to clear were also more likely to transmit their drug-resistant strain to others.

    Mr. White urged more radical action, such as targeted malaria elimination, to prevent the spread of resistance. The approach would require officials to identify people who are healthy but carry malarial parasites, especially on western border of Myanmar.

    “The artemisinin drugs are arguably the best antimalarials we have ever had. We need to conserve them in areas where they are still working well,” said Elizabeth Ashley, the lead scientist of the study.

    New antimalarial medicines are being developed and have shown some promise, but are unlikely to be available for distribution for several years, another paper published in the New England Journal of Medicine showed.

    #paludisme #moustique